Mitsubishi Tanabe Pharma America, Inc. | Company Profile, Marketing Contacts, Media Spend, Brands

Mitsubishi Tanabe Pharma America, Inc. (MTPA) is committed to providing significant scientific advances designed to provide important treatments to those facing serious and life-threatening diseases. MTPA is a wholly-owned subsidiary of Mitsubishi Tanabe Pharma Corporation (MTPC). MTPC is one of the world’s oldest medicines companies, with over 300 years of experience advancing innovative treatments. In 2009, MTPC opened its first U.S. headquarters with a focus on developing and commercializing new compounds for the U.S. market. MTPA officially launched in 2016 with the ambitious goal of developing therapies for some of the most difficult-to-treat diseases, including amyotrophic lateral sclerosis (ALS).